Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
45.70
-0.45 (-0.99%)
Sep 18, 2025, 3:05 PM EDT - Market open
BMY Revenue
Bristol-Myers Squibb Company had revenue of $12.27B in the quarter ending June 30, 2025, with 0.56% growth. This brings the company's revenue in the last twelve months to $47.70B, up 2.57% year-over-year. In the year 2024, Bristol-Myers Squibb Company had annual revenue of $48.30B with 7.32% growth.
Revenue (ttm)
$47.70B
Revenue Growth
+2.57%
P/S Ratio
1.96
Revenue / Employee
$1,398,944
Employees
34,100
Market Cap
93.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 48.30B | 3.29B | 7.32% |
Dec 31, 2023 | 45.01B | -1.15B | -2.50% |
Dec 31, 2022 | 46.16B | -226.00M | -0.49% |
Dec 31, 2021 | 46.39B | 3.87B | 9.09% |
Dec 31, 2020 | 42.52B | 16.37B | 62.62% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
BMY News
- 6 hours ago - Dividend Harvesting Portfolio Week 237: $23,700 Allocated, $2,573.68 In Projected Dividends - Seeking Alpha
- 1 day ago - J&J's experimental psoriasis drug shows promise against Bristol's treatment - Reuters
- 1 day ago - Bristol Myers Squibb Announces Dividend - Business Wire
- 1 day ago - Bristol Myers to sell 60% stake in China joint venture - Reuters
- 2 days ago - 10 Quality High Yield In Rose's Income Garden Portfolio: 5 Winners To Buy - Seeking Alpha
- 2 days ago - These stock-market experts don't love AI. Here's what they do recommend. - Market Watch
- 2 days ago - Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum - Business Wire
- 5 days ago - Meet 16 Ideal "Safer" September Dividend Dogs Of The S&P500 - Seeking Alpha